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INTRODUCTION
Articular cartilage degeneration with advancing age
results in osteoarthritis, a leading cause of morbidity
across the world.1,2 Defects in the cartilage may also
occur in young age due to reasons such as injury and
overuse, but quite often no underlying cause can be
found. One such cartilage affliction is osteochondritis
dissecans of the knee, which typically affects young
adults and entails a full-thickness defect in the articular
cartilage. At the outset, it causes significant symptoms
and restriction of function, and later on, it may result in
progressive cartilage degeneration and early onset
osteoarthritis.3,4 Thus, adequate treatment is of utmost
importance in such patients.5
We report a case of osteochondritis dissecans of the
medial femoral condyle, where successful outcome was
achieved by the use of autologous chondrocyte
implantation (ACI).
CASE REPORT
A 28-year-old lady, housewife, presented with a six-
month history of insidious onset pain in the left knee
joint. This was associated with intermittent locking of the
joint with flexion and extension, requiring jerky
movements to “unlock” the knee. Moreover, she often
felt something moving inside her joint; typical of a “joint
mouse”. 
Physical examination revealed a mild effusion, crepitus
and medial joint line tenderness. She had a positive
McMurray’s test for the medial meniscus. Clinical
impression was that of a torn meniscus or a loose body.
Plain X-rays were unremarkable. MRI scan showed a
full-thickness osteochondral defect at the anterior
middle portion of the medial femoral condyle, a free-
floating cartilage fragment and normal menisci and
ligaments. An arthroscopy was performed whereby
these findings were confirmed. A 2x2 cm full-thickness
osteochondral defect (Outerbridge grade IV) was noted
(Figure 1A,B). This defect was drilled down to bleeding
subchondral bone with multiple passes of 20-gauge
K-wire (Figure 1D,E). A free floating cartilage fragment
was found (Figure 1C), extracted and placed in cell
culture medium with full sterile precautions. The medium
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CASE REPORT
Figure 1 (A-E): Arthroscopic images showing (A) large defect (arrows) in the
posterolateral aspect of the medial femoral condyle; (B) defect thickness
confirmed by probing bone in the base of the defect; (C) extraction of free
floating articular cartilage fragment; (D) abrasion of the defect and (E) drilling
of defect with 20-gauge K-wire. m=medial meniscus, t=tibial articular
comprised of DME/HAM F-12 1:1 mixture with 15 mM
HEPES, supplemented with 10% Fetal bovine serum,
1.25 mg/ml Ascorbic acid, 50 µg/ml insulin, 50 µg/ml
Transferrin, 5 µg/ml Selenium and 1 x antibiotics and
antimycotic solution. All reagents were obtained from
Sigma-Aldrich (St Louis, MO, USA).
The cartilage fragment was transported to the Aga Khan
University basic science laboratory (Juma Research
Laboratory). It was washed thoroughly with serum free
medium to remove any traces of blood and transferred
to a sterile plastic Petri dish to facilitate handling. With
the help of scalpel blade the outer surface was gently
abraded to reduce the chance of fibroblast
contamination and then chopped into small pieces.
Finally, the cartilage bits were transferred to 50 ml tube
containing 0.125% collagenase IV enzyme in serum free
medium and incubated overnight at 37°C with gentle
rocking.
Next day, the digested cartilage material was filtered
through sterile 100 micron cell strainer (Falcon, Franklin
Lake, New Jersey, USA) to remove big undigested
pieces. Filtered cells were centrifuged at 1000 rpm for
5 minutes and washed once with complete medium
before they were seeded in 25 cm2 tissue culture flasks
(Falcon, Franklin Lake, New Jersey, USA). Flasks
were incubated in a humidified chamber in 5% CO2
atmosphere without any physical disturbance for
48 hours to aid attachment of cells. Thereafter, the
medium was changed
every 48 hours. Flasks
were observed daily for
any signs of contam-
ination. Each flask was
subcultured into two flasks
of the same size when
the cells reached 80%
confluency. At the third
passage, cells were
harvested and stored in
cell-freezing medium in
liquid nitrogen.
Two weeks before surgery,
the frozen cells were
revived from liquid
nitrogen and subcultured.
Cells were also grown on








cells while the anti- S-100
antibody differentiates chondrocyte cell type from
fibroblasts as S-100 protein is expressed in
chondrocytes and not fibroblasts. Cells were positive for
both antigens, confirming the chondrocyte phenotype of
the cells (Figure 2A-C).
At the day of the surgery, the cells were harvested from
the tissue culture flasks and aliquots were sent to
surgery room when the surgeon was ready for the
transplantation. In the operating room, an arthroscopy
was performed first, and it was noted that the cartilage
defect persisted with presence of old organized clot in
the base. An open arthrotomy was then performed and
the defect debrided (Figure 3A). A periosteal patch was
harvested from the mid-tibial shaft, and the outer
surface was marked with a marking pen (Figure 3B).
The flap was reversed such that the inner endosteal
surface faced outside and sewn onto the defect margins
using 6/0 vicryl sutures applied in a continuous running
fashion, to achieve an airtight seal (Figure 3C). The
margins were further sealed using BeriPlast™ fibrin glue
(Figure 3D). The cultured autologous chondrocytes
were injected under the periosteal patch using a
27 gauge needle. No leakage of the injected fluid was
noted.
Postoperatively, the patient was permitted active knee
range of motion, but restricted from weight bearing for
six weeks. The patient reported gradual improvement in
pain and range of motion, such that she became
completely asymptomatic after three months.
Examination showed full, painless range of motion and
ability to squat and get up with ease. A follow-up MRI
done six months after the transplant confirmed filling of
the defect. She also consented to a check arthroscopy,
which was done one year after the transplant. The
previous defect was completely filled with normal-
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Figure 2 (A-C):  Photomicrographs
showing (A) chondrocyte-like cells  in
culture medium as observed
under phase contrast microscopy;
immunocytochemistry images show-
ing cells positive for S-100 (B) and
vimentin (C). Objective=20x.
Figure 3 (A-D): (A) Osteochondral defect. (B) Periosteal patch harvested
from  tibia, outer surface of periosteal patch marked. (C) Patch reversed and
sewn  onto margins of defect with 6/0 vicryl sutures. (D) Margins sealed with
fibrin glue  and chondrocyte suspension injected underneath the defect.
looking cartilage.
DISCUSSION
This is the first reported case of successful ACI in
Pakistan. Nearby countries where it has been started
are India and Singapore.
The real challenge in the treatment of articular cartilage
defects is the restoration of a smooth joint surface
composed of hyaline cartilage. The natural history of
untreated cartilage defects is usually replacement with
fibrous tissue. With surgical therapy such as abrasion
chondroplasty and drilling, fibrocartilage formation is
induced. Both fibrous tissue and fibrocartilage have
different surface characteristics and biomechanical
properties as compared to the native hyaline cartilage.
Thus, early good results are not maintained over a long-
term.6 Another technique, mosaicplasty, has been
claimed to result in formation of hyaline cartilage, but it
entails extensive surgery on the normal cartilage and
cannot be applied to large defects. Autografts
comprising of osteochondral fragments have shown
good promise viz-a-viz restoration of the hyaline
cartilage, but are associated with donor site morbidity,
which increases with increasing size of the graft or
defect. Allografts circumvent these limitations, but have
their own limitations regarding availability and graft
rejection by the recipient’s immune system. More
recently, autologous chondrocyte implantation7
(Figure 4) has emerged as a promising tool. It utilizes
patient’s own cartilage cells and potentially results in
restoration of near-normal hyaline cartilage. It has
minimal, if any, donor site morbidity and, therefore, can
be used to fill large defects.8,9 However, it entails two
procedures, one for harvesting the cartilage cells and
second for implanting the cells and requires a basic
science laboratory setup with cell-culture facility.
Nevertheless, upto 90% good-excellent long-term
results have been reported with this technique.
In Aga Khan University, with the establishment of the
Juma Research Laboratory, a modern cell-culture facility
has been setup. In the future, this technology can be
utilized for treating patients with a variety of conditions
affecting hyaline cartilage of joints
REFERENCES
1. Woolf AD, Pfleger B. Burden of major musculoskeletal
conditions. Bull World Health Organ 2003; 81: 646-56.
2. Brooks PM. The burden of musculoskeletal disease: a global
perspective. Clin Rheumatol 2006; 25: 778-81.
3. Cahill BR. Osteochondritis dissecans of the knee: treatment of
juvenile and adult forms. J Am Acad Orthop Surg 1995; 3: 237-47.
4. Linden B. Osteochondritis dissecans of the femoral condyles: a
long-term follow-up study. J Bone Joint Surg Am 1977; 59: 769-76.
5. Federico DJ, Lynch JK, Jokl P. Osteochondritis dissecans of the
knee: a historical review of etiology and treatment. Arthroscopy
1990; 6:190-7.
6. Smith GD, Knutsen G, Richardson JB. A clinical review of
cartilage repair techniques. J Bone Joint Surg Br 2005; 87:445-9.
7. Oakes BW. Orthopaedic tissue engineering: from laboratory to
the clinic. Med J Aust 2004;180(5 Suppl):S35-8.
8. Brittberg M, Lindhal A, Nilsson A, Ohlsson C, Isaksson O,
Peterson L. Treatment of deep cartilage defects in the knee with
autologous chondrocyte transplantation. N Engl J Med 1994; 331:
889-95.
9. Briggs TW, Mahroof S, David LA, Flannelly J, Pringle J,
Bayliss M. Histological evaluation of chondral defects after
autologous chondrocyte implantation of the knee. J Bone Joint Surg Br
2003; 85:1077-83. 
Journal of the College of Physicians and Surgeons Pakistan  2008, Vol. 18 (3): 185-187 187
Autologous chondrocyte implantation
Figure 4: Drawings depicting hyaline cartilage regeneration following
autologous  chondrocyte implantation. The articular cartilage defect is
debrided down to subchondral bone. A reversed periosteal patch with the
“cambium” layer of  osteoprogenitor cells facing down into the defect is
carefully sutured onto the  outer margins of defect (end to side) with
interrupted 6/0 sutures and sealed  with fibrin glue to ensure a water-tight
chondral–periosteal compartment.  Cultured chondrocytes are then injected
carefully into the “contained” defect.  These cells settle, adhere and
proliferate, and also lay down new hyaline  cartilage, resembling the native
cartilage. Source: Oakes BW. Orthopaedic tissue  engineering: from
laboratory to the clinic. MJA 2004; 180: S35-S38. ©Copyright  2004. The
Medical Journal of Australia - reproduced with permission.
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